Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 374 (RNA5SP374)
- Target
- RNA5SP374
- Molecular classification
- Pseudogene, ribosomal RNA pseudogene
01
Overview
RNA, 5S ribosomal pseudogene 374 (RNA5SP374) is a human pseudogene related to the 5S ribosomal RNA gene. Pseudogenes arise from gene duplication or retrotransposition events and accumulate mutations impairing their ability to encode a functional RNA or protein. The original 5S ribosomal RNA is an integral part of the ribosomal large subunit, participating in ribosome structure and function, but RNA5SP374 is non-functional and does not contribute to ribosome activity. While pseudogenes can contribute to gene regulation in some contexts—for example, by acting as competing endogenous RNAs—no direct biological role or disease association is established for RNA5SP374 specifically. Pseudogene expression profiling in cancer research highlights the biomarker and regulatory potential of certain pseudogenes, but this is not established for RNA5SP374 itself.
- Other names
- RN5S374RNA, 5S ribosomal 374RNA5SP374
02
Mechanism of action
Not applicable. There are no drugs that target this pseudogene, nor is a mechanism of action for drug targeting known.
03
Biological functions
Typically, pseudogenes such as RNA5SP374 do not encode functional proteins or RNAs.However, some pseudogenes can regulate gene expression, function as competing endogenous RNAs (ceRNAs), or participate in genomic regulatory networks.The direct biological functions for RNA5SP374 itself are not established.
04
Disease associations
No established direct rolespseudogene expression patterns (as a class, but not specifically RNA5SP374) have been implicated as biomarkers for cancer subtyping and prognosis.Direct evidence for RNA5SP374 in disease is lacking
05
Safety considerations
None knownas a non-coding, non-functional pseudogene, RNA5SP374 does not pose safety or therapeutic challenges.
06
Interacting drugs
None known. Pseudogenes do not serve as drug targets in conventional pharmacology.
07
Biomarkers
As a class, some pseudogenes (but not specifically RNA5SP374) exhibit prognostic or diagnostic biomarker potential in oncology.RNA5SP374 has no documented biomarker role to date.
Beyond the preview
Go deeper on RNA, 5S ribosomal pseudogene 374 (RNA5SP374).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 374 (RNA5SP374).